,0
zip,10016
sector,Healthcare
fullTimeEmployees,32200
longBusinessSummary,"Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York."
city,New York
phone,212 546 4000
state,NY
country,United States
companyOfficers,[]
website,https://www.bms.com
maxAge,1
address1,430 East 29th Street
industry,Drug Manufacturersâ€”General
address2,14th Floor
ebitdaMargins,0.44366002
profitMargins,0.15078
grossMargins,0.79871005
operatingCashflow,16206999552
revenueGrowth,0.083
operatingMargins,0.21174999
ebitda,20579000320
targetLowPrice,65
recommendationKey,buy
grossProfits,37048000000
freeCashflow,13574250496
targetMedianPrice,73.5
currentPrice,73.28
earningsGrowth,
currentRatio,1.521
returnOnAssets,0.0539
numberOfAnalystOpinions,20
targetMeanPrice,74.13
debtToEquity,126.634
returnOnEquity,0.18985
targetHighPrice,94
totalCash,17220999168
totalDebt,45596000256
totalRevenue,46385000448
totalCashPerShare,7.901
financialCurrency,USD
revenuePerShare,20.885
quickRatio,1.36
recommendationMean,2.1
exchange,NYQ
shortName,Bristol-Myers Squibb Company
longName,Bristol-Myers Squibb Company
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,BMY
messageBoardId,finmb_25798
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,4.057
beta3Year,
enterpriseToEbitda,9.144
52WeekChange,0.143749
morningStarRiskRating,
forwardEps,8.25
revenueQuarterlyGrowth,
sharesOutstanding,2179709952
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,16.519
sharesShort,53732263
sharesPercentSharesOut,0.0247
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.77578
netIncomeToCommon,6993999872
trailingEps,3.12
lastDividendValue,0.54
SandP52WeekChange,0.14403355
priceToBook,4.436104
heldPercentInsiders,0.00075
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1640908800
shortRatio,3.41
sharesShortPreviousMonthDate,1644883200
floatShares,2171887651
beta,0.531496
enterpriseValue,188164358144
priceHint,2
threeYearAverageReturn,
lastSplitDate,997142400
lastSplitFactor,1000000:951777
legalType,
lastDividendDate,1648684800
morningStarOverallRating,
earningsQuarterlyGrowth,
priceToSalesTrailing12Months,3.4435515
dateShortInterest,1647302400
pegRatio,1.85
ytdReturn,
forwardPE,8.882424
lastCapGain,
shortPercentOfFloat,0.0247
sharesShortPriorMonth,70881353
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,72.41
regularMarketOpen,72.5
twoHundredDayAverage,63.85615
trailingAnnualDividendYield,0.027758595
payoutRatio,0.64419997
volume24Hr,
regularMarketDayHigh,73.455
navPrice,
averageDailyVolume10Day,17048730
regularMarketPreviousClose,72.41
fiftyDayAverage,67.2794
trailingAnnualDividendRate,2.01
open,72.5
toCurrency,
averageVolume10days,17048730
expireDate,
algorithm,
dividendRate,2.16
exDividendDate,1648684800
circulatingSupply,
startDate,
regularMarketDayLow,72.45
currency,USD
trailingPE,23.48718
regularMarketVolume,11697066
lastMarket,
maxSupply,
openInterest,
marketCap,159729139712
volumeAllCurrencies,
strikePrice,
averageVolume,14293677
dayLow,72.45
ask,73.38
askSize,1300
volume,11697066
fiftyTwoWeekHigh,73.46
fromCurrency,
fiveYearAvgDividendYield,2.94
fiftyTwoWeekLow,53.22
bid,73.36
tradeable,False
dividendYield,0.0298
bidSize,1300
dayHigh,73.455
regularMarketPrice,73.28
preMarketPrice,
logo_url,https://logo.clearbit.com/bms.com
